“The apprehension with applying non IID listed ingredients is justified as it is extremely hard To judge if FDA would discover the ‘novel excipient’ Risk-free to be used within a drug products as there is not any described approach for analysis and approval of excipients. The FDA direction on https://proleviate.com/